期刊文献+

建立转录丙型肝炎病毒结构区基因细胞模型的研究 被引量:2

Study on establishment of cellular model transcripting HCV structural genes
下载PDF
导出
摘要 目的 :建立转录丙型肝炎病毒 (HCV)结构区基因的细胞模型 ,为研究中药在体外对HCV结构区基因转录的抑制作用提供实验用细胞模型。方法 :用脂质体将已构建好的含HCV结构区基因 1.73kb的真核细胞表达载体pBK CMV转入人HeLa细胞 ,用G418选择性培养基筛选出成功转染的HeLa细胞 (HeLaD细胞 ) ,用Trizol提取HeLaD细胞的总RNA ,通过特异性引物进行逆转录 聚合酶链反应 (RT PCR) ,从mRNA水平来验证HeLaD细胞中HCV结构区基因的有效转录。结果 :对从HeLaD细胞抽提的总RNA作RT PCR ,得到 14 4bp的特异的扩增片段 ,证实HCV结构区基因在HeLaD细胞中有转录水平的表达。结论 :重组质粒pBK CMV能被成功地转染人HeLa细胞 ,且HCV的结构区基因能够有效地表达 ,成功建立了能转录HCV结构区基因的细胞模型 HeLaD。 Objective In order to study the effect of Chinese herbs' on the transcription of hepatitis C virus (HCV) structural genes,the cell model being able to transcript the HCV structural genes was established.Methods Using lipofectin,human HeLa cells were transfected with the eukaryotic expression vector pBK-CMV which contained HCV structural gene fragments 1.73-kb.The selective medium containing G418(600-mg·L -1) was used to select the correctly trasfected HeLa cells that was named as HeLaD.Then the total RNA of the transfected HeLa cells was extracted by Trizol reagent and RT-PCR assays were used to further verify the HCV structural gene fragments in mRNA level.Results The RT-PCR results showed that a specific product of 144-bp DNA fragment could be seen in HeLa-D cells transfected with the recombinant plasmid pBK-CMV indicating that the HeLa-D cells could transcript the HCV structural genes successfully.Conclusion Human HeLa cells can be transfected with the HCV structural genes.Further more,the HCV genes can be expressed and transcripted successfully in the HeLa-D cells.
作者 陈前 窦骏
出处 《东南大学学报(医学版)》 CAS 2004年第1期31-33,共3页 Journal of Southeast University(Medical Science Edition)
基金 江苏省中医药管理局科技发展基金资助项目 (J97Z0 0 3) 南京中医药大学 96攻关项目
关键词 丙型肝炎病毒 基因细胞 细胞模型 HCV 遗传学 HELA细胞 hepatitis c-like viruses/genetics HeLa cells genetic vectors trnsfection
  • 相关文献

参考文献2

共引文献11

同被引文献28

  • 1刘雪松.丙型肝炎防治指南[J].中华医学杂志,2004,84(9):775-780. 被引量:64
  • 2刘水平,谭德明,杨永峰,侯周华.丙型肝炎病毒5'端非编码区和NS3蛋白酶共调控外分泌性碱性磷酸酶表达细胞模型的建立及意义[J].中华肝脏病杂志,2004,12(9):552-554. 被引量:2
  • 3池晓霞,谢妮,孙彦.一种新型抗HCV药物筛选细胞模型建立的研究[J].深圳中西医结合杂志,2005,15(4):216-219. 被引量:3
  • 4STRADER D B,WRIGHT T,THOMAS D L,et al.Diagnosis,management,and treatment of hepatitis C[J].Hepatology,2004,39(4):1147-1171.
  • 5MCHUTCHISON J G.HEPATITIS C advances in antiviral therapy:what is accepted treatment now[J].J Gastroenterol Hepatol,2002,17(4):431 -441.
  • 6ALT M,RENZ R,HOFSCHNEIDER P H,et al.Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides[J].Hepatology,1995,22 (3):707-717.
  • 7HANECAK R,BROWN-DRIVER V,FOX M C,et al.Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes[J].J Virol,1996,70 (8):5203-5212.
  • 8MORADPOUR D,EEGLERT C,WAKITA T,et al.Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein[J].Virology,1996,222(1):51-63.
  • 9IDE Y,TANIMOTO A,SASAGURI Y,et al.Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-alpha catalytic subunit[J].Gene,1997,201 (1 -2):151-158.
  • 10KING R W,ZECHER M,JEFFRIES M W,et al.A cell-based model of HCV-negative-strand RNA replication utilizing a chimeric hepatitis C virus/reporter RNA template.Antivir Chem Chemother,2002,13(6):353 -62.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部